Home › Trial NCT03891953
Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.
- Trial IDNCT03891953
- StatusActive Not Recruiting
- PhasePhase 1
- Study typeInterventional
- SponsorNovartis Pharmaceuticals
- Enrollment98
- Start date2019-05-07
- ConditionsCarcinoma, Non-Small-Cell Lung · Melanoma · Nasopharyngeal Carcinoma · Microsatellite Stable Colorectal Cancer · Triple Negative Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.